Get 20% lifetime commission for referring investors to digrin.com
here.
InflaRx N.V. ( IFRX) - Key Metrics
IFRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.09 | -$0.02 | -$0.02 |
| 2026Q1 | $0 | -$0.08 | -$0.10 | -$0.10 |
| 2025Q4 | $0 | -$0.16 | -$0.07 | -$0.07 |
| 2025Q3 | $0 | -$0.18 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.21 | -$0.11 | -$0.11 |
IFRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.45 |
| 2026Q1 | 0% | -2.46 |
| 2025Q4 | 0% | -1.54 |
| 2025Q3 | 0% | -1.59 |
| 2025Q2 | 0% | -0.80 |
IFRX
Price: $1.32
52 week price:
Earnings Per Share: -0.58 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Germany
Volume: 38219
Market Capitalization: 232.7 million